117 related articles for article (PubMed ID: 3040609)
1. Cyclic AMP and cyclic GMP phosphodiesterase activities in Hodgkin's disease lymphocytes.
Aleksijevic A; Lugnier C; Giron C; Mayer S; Stoclet JC; Lang JM
Int J Immunopharmacol; 1987; 9(5):525-31. PubMed ID: 3040609
[TBL] [Abstract][Full Text] [Related]
2. Activation of cyclic nucleotide phosphodiesterase from isolated human peripheral blood lymphocytes by mitogenic agents.
Epstein PM; Mills JS; Hersh EM; Strada SJ; Thompson WJ
Cancer Res; 1980 Feb; 40(2):379-86. PubMed ID: 6243252
[No Abstract] [Full Text] [Related]
3. Serum cyclic 3',5'-nucleotide phosphodiesterase in patients with various thyroid disorders.
Nagasaka A; Hasegawa H; Hayami S; Hidaka H; Tanaka T; Niinomi M; Nihei N; Nakagawa H; Ohyama T; Aono T
Enzyme; 1985; 33(1):18-24. PubMed ID: 2985379
[TBL] [Abstract][Full Text] [Related]
4. Phosphatidylethanolamine methyltransferase and cAMP, cGMP phosphodiesterases in lymphocytes and monocytes in sarcoidosis.
Pacheco Y; Dubois M; Prigent AF; Fonlupt P; Timouyasse L; Rey C; Chambe MT; Biot N; Perrin-Fayolle M; Pacheco H
Clin Chim Acta; 1987 Mar; 163(3):267-77. PubMed ID: 3034451
[TBL] [Abstract][Full Text] [Related]
5. High activity of cyclic 3',5'-nucleotide phosphodiesterase in sera of patient with phaeochromocytoma.
Nakai A; Nagasaka A; Ohyama T; Aono T; Iwase K; Hasegawa H; Hayami S; Hidaka H; Tanaka T; Niinomi M
Clin Endocrinol (Oxf); 1986 Apr; 24(4):409-14. PubMed ID: 3017609
[TBL] [Abstract][Full Text] [Related]
6. Activity of cyclic nucleotide phosphodiesterases in granulocytes of chronic myelogenous leukemia (CML). A preliminary report.
Naskalski JW; Uciński WS
Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(1):134-40. PubMed ID: 2581858
[TBL] [Abstract][Full Text] [Related]
7. Cyclic nucleotide phosphodiesterases from purified human CD4+ and CD8+ T lymphocytes.
Tenor H; Staniciu L; Schudt C; Hatzelmann A; Wendel A; Djukanović R; Church MK; Shute JK
Clin Exp Allergy; 1995 Jul; 25(7):616-24. PubMed ID: 8521180
[TBL] [Abstract][Full Text] [Related]
8. The effect of diamide on cyclic AMP levels and cyclic nucleotide phosphodiesterase in human peripheral blood lymphocytes.
Wedner HJ
Biochim Biophys Acta; 1980 Apr; 628(4):407-18. PubMed ID: 6245710
[TBL] [Abstract][Full Text] [Related]
9. Characterization of cyclic-nucleotide phosphodiesterase activities in resting and N-formylmethionylleucylphenylalanine-stimulated human neutrophils.
Grady PG; Thomas LL
Biochim Biophys Acta; 1986 Mar; 885(3):282-93. PubMed ID: 3004603
[TBL] [Abstract][Full Text] [Related]
10. Cyclic AMP metabolism in peripheral blood lymphocytes from patients with Hodgkin's disease.
Akolkar PN; Advani SH; Gothoskar BP
Eur J Cancer Clin Oncol; 1984 Nov; 20(11):1389-92. PubMed ID: 6094195
[TBL] [Abstract][Full Text] [Related]
11. Cyclic nucleotide phosphodiesterase activity and the platelet release reaction.
Taylor PM; Heptinstall S
Thromb Haemost; 1978 Apr; 39(2):550-1. PubMed ID: 27878
[No Abstract] [Full Text] [Related]
12. Alterations of peripheral blood lymphocyte cyclic AMP and cyclic GMP in untreated patients with hodgkin's disease.
Aleksijevic A; Lang JM; Giron C; Stoclet JC; Mayer S; Oberling F
Clin Immunol Immunopathol; 1983 Mar; 26(3):398-405. PubMed ID: 6307567
[TBL] [Abstract][Full Text] [Related]
13. Purification and characterization of a human platelet cyclic nucleotide phosphodiesterase.
Grant PG; Colman RW
Biochemistry; 1984 Apr; 23(8):1801-7. PubMed ID: 6326810
[TBL] [Abstract][Full Text] [Related]
14. Purification and characterization of a cyclic GMP-stimulated cyclic nucleotide phosphodiesterase from the cytosol of human platelets.
Grant PG; Mannarino AF; Colman RW
Thromb Res; 1990 Jul; 59(1):105-19. PubMed ID: 2169075
[TBL] [Abstract][Full Text] [Related]
15. Cyclic 3':5'-adenosine monophosphate phosphodiesterase and cyclic 3':5'-guanosine monophosphate phosphodiesterase of normal granulocytes and granulocytes of chronic myelogenous leukaemia.
Uciński WS; Naskalski JW
Haematologia (Budap); 1986; 19(4):275-83. PubMed ID: 3028916
[TBL] [Abstract][Full Text] [Related]
16. Serum cyclic 3',5'-nucleotide phosphodiesterase activity in myocardial infarction.
Nagasaka A; Nishijima K; Hidaka H; Tanaka T; Yoshida S; Nakai A; Ohyama T; Mizuno Y
Acta Cardiol; 1985; 40(6):613-20. PubMed ID: 3006409
[TBL] [Abstract][Full Text] [Related]
17. Do conventional plasma cyclic nucleotide phosphodiesterase inhibitors really work in all situations?
Wood PJ; Pao G; Ross G; Smith C
Clin Chim Acta; 1981 Sep; 115(3):405-8. PubMed ID: 6271425
[No Abstract] [Full Text] [Related]
18. S-100 antigen and calmodulin in human leukemic cells.
Wada H; Shirakawa S; Yamakado T; Ohkubo S; Tanaka T; Yamamoto T; Hidaka H
Leuk Res; 1989; 13(1):65-9. PubMed ID: 2536871
[TBL] [Abstract][Full Text] [Related]
19. Cyclic nucleotide phosphodiesterase inhibition by a benzoic acid derivative.
Killackey JJ; Killackey BA; Philp RB
Agents Actions; 1985 Dec; 17(2):192-6. PubMed ID: 2420162
[TBL] [Abstract][Full Text] [Related]
20. Studies on plasma cyclic nucleotide, cyclic nucleotide phosphodiesterase, beta-thromboglobulin, and myoglobin response in patients with acute myocardial infarction.
Kurokawa Y; Fukuda I; Mozai T
Bull Osaka Med Sch; 1983 Oct; 29(2):85-97. PubMed ID: 6210124
[No Abstract] [Full Text] [Related]
[Next] [New Search]
